180 related articles for article (PubMed ID: 36341281)
1. MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation.
Crow J; Samuel G; Farrow E; Gibson M; Johnston J; Guest E; Miller N; Pei D; Koestler D; Pathak H; Liang X; Mangels C; Godwin AK
Biomark Insights; 2022; 17():11772719221132693. PubMed ID: 36341281
[No Abstract] [Full Text] [Related]
2. Ewing sarcoma family of tumors-derived small extracellular vesicle proteomics identify potential clinical biomarkers.
Samuel G; Crow J; Klein JB; Merchant ML; Nissen E; Koestler DC; Laurence K; Liang X; Neville K; Staggs V; Ahmed A; Atay S; Godwin AK
Oncotarget; 2020 Aug; 11(31):2995-3012. PubMed ID: 32821345
[TBL] [Abstract][Full Text] [Related]
3. Identification of small extracellular vesicle protein biomarkers for pediatric Ewing Sarcoma.
Turaga SM; Sardiu ME; Vishwakarma V; Mitra A; Bantis LE; Madan R; Merchant ML; Klein JB; Samuel G; Godwin AK
Front Mol Biosci; 2023; 10():1138594. PubMed ID: 37122563
[TBL] [Abstract][Full Text] [Related]
4. Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells.
Grohar PJ; Griffin LB; Yeung C; Chen QR; Pommier Y; Khanna C; Khan J; Helman LJ
Neoplasia; 2011 Feb; 13(2):145-53. PubMed ID: 21403840
[TBL] [Abstract][Full Text] [Related]
5. A molecular function map of Ewing's sarcoma.
Kauer M; Ban J; Kofler R; Walker B; Davis S; Meltzer P; Kovar H
PLoS One; 2009; 4(4):e5415. PubMed ID: 19404404
[TBL] [Abstract][Full Text] [Related]
6. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ
J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923
[TBL] [Abstract][Full Text] [Related]
7. GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors.
Joo J; Christensen L; Warner K; States L; Kang HG; Vo K; Lawlor ER; May WA
PLoS One; 2009 Oct; 4(10):e7608. PubMed ID: 19859563
[TBL] [Abstract][Full Text] [Related]
8. Modeling initiation of Ewing sarcoma in human neural crest cells.
von Levetzow C; Jiang X; Gwye Y; von Levetzow G; Hung L; Cooper A; Hsu JH; Lawlor ER
PLoS One; 2011 Apr; 6(4):e19305. PubMed ID: 21559395
[TBL] [Abstract][Full Text] [Related]
9. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A; Toretsky JA
Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
[TBL] [Abstract][Full Text] [Related]
10. Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development.
De Vito C; Riggi N; Suvà ML; Janiszewska M; Horlbeck J; Baumer K; Provero P; Stamenkovic I
PLoS One; 2011; 6(8):e23592. PubMed ID: 21853155
[TBL] [Abstract][Full Text] [Related]
11. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.
Ban J; Bennani-Baiti IM; Kauer M; Schaefer KL; Poremba C; Jug G; Schwentner R; Smrzka O; Muehlbacher K; Aryee DN; Kovar H
Cancer Res; 2008 Sep; 68(17):7100-9. PubMed ID: 18757425
[TBL] [Abstract][Full Text] [Related]
12. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
Ban J; Siligan C; Kreppel M; Aryee D; Kovar H
Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154
[TBL] [Abstract][Full Text] [Related]
13. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
14. Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors.
Zhang P; Samuel G; Crow J; Godwin AK; Zeng Y
Transl Res; 2018 Nov; 201():136-153. PubMed ID: 30031766
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.
Aryee DN; Niedan S; Kauer M; Schwentner R; Bennani-Baiti IM; Ban J; Muehlbacher K; Kreppel M; Walker RL; Meltzer P; Poremba C; Kofler R; Kovar H
Cancer Res; 2010 May; 70(10):4015-23. PubMed ID: 20442286
[TBL] [Abstract][Full Text] [Related]
16. GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.
Beauchamp E; Bulut G; Abaan O; Chen K; Merchant A; Matsui W; Endo Y; Rubin JS; Toretsky J; Uren A
J Biol Chem; 2009 Apr; 284(14):9074-82. PubMed ID: 19189974
[TBL] [Abstract][Full Text] [Related]
17. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
[TBL] [Abstract][Full Text] [Related]
18. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis.
Ma Y; Baltezor M; Rajewski L; Crow J; Samuel G; Staggs VS; Chastain KM; Toretsky JA; Weir SJ; Godwin AK
J Mol Med (Berl); 2019 Jul; 97(7):957-972. PubMed ID: 31025088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
